| Application no. and date | 02740570.3 (espacenet) (Federated) (European Patent Register), 20020507 | | Patent/reg. no. and date | DK/EP 1392314, 20061220 | | Publication date | 20040303 | | Priority no. and date | DE 10122576, 20010509, DE 10126198, 20010530 | | EP pub. no. and date |
EP 1392314 20040303 | | Effective date | | | Applicant/owner | Bayer HealthCare AG,
51368 Leverkusen, DE | | Applicant ref. no. | 127741 | | Inventor | BANDEL, Tiemo-Joerg, Ebersbachstr. 70a
46145 Oberhausen, DE,
BISCHOFF, Erwin, Pahlkestr. 73
42115 Wuppertal, DE,
NIEWÖHNER, Ulrich,
deceased, DE,
HANING, Helmut, Pahlkestr. 17
42115 Wuppertal, DE,
BARTH, Wolfgang, Berghauser Str. 37
42349 Wuppertal, DE,
VAN DER STAAY, Franz-Josef, Saturnusweg 10
8251 BB Dronten, NL,
RAHBAR, Afssaneh, Fasanenweg 15
50226 Frechen, DE | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/53 (2006.01) , A61P 25/28 (2006.01) | | Title | Hidtil ukendt anvendelse af 2-[2-ethoxy-5-(4-methyl-piperazin-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]-triazin-4-on | | Int. application no. | EP2002005002 | | Int. publication no. | WO2002089808 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
